These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Socioeconomic and racial disparities of pediatric invasive pneumococcal disease after the introduction of the 7-valent pneumococcal conjugate vaccine. Spicer JO; Thomas S; Holst A; Baughman W; Farley MM Pediatr Infect Dis J; 2014 Feb; 33(2):158-64. PubMed ID: 24418837 [TBL] [Abstract][Full Text] [Related]
5. Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine. Hsu K; Pelton S; Karumuri S; Heisey-Grove D; Klein J; Pediatr Infect Dis J; 2005 Jan; 24(1):17-23. PubMed ID: 15665705 [TBL] [Abstract][Full Text] [Related]
6. Epidemiology, vaccine effectiveness, and risk factors for mortality for pneumococcal disease among hospitalised adults in Singapore: a case-control study. Chan T; Tay MZ; Kyaw WM; Chow A; Ho HJ BMC Infect Dis; 2020 Jun; 20(1):423. PubMed ID: 32552726 [TBL] [Abstract][Full Text] [Related]
7. The Effect of 13-Valent Pneumococcal Conjugate Vaccine on the Serotype Distribution and Antibiotic Resistance Profiles in Children With Invasive Pneumococcal Disease. Gaviria-Agudelo CL; Jordan-Villegas A; Garcia C; McCracken GH J Pediatric Infect Dis Soc; 2017 Sep; 6(3):253-259. PubMed ID: 26907814 [TBL] [Abstract][Full Text] [Related]
8. Serotypes and Clonal Composition of Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 to 2019 Systematic Introduction of PCV13. Redin A; Ciruela P; de Sevilla MF; Gomez-Bertomeu F; Gonzalez-Peris S; Benitez MA; Trujillo G; Diaz A; Jou E; Izquierdo C; Perez-Moreno MO; Moraga-Llop F; Olsina M; Vinado B; Sanfeliu E; Garcia A; Gonzalez-di Lauro S; Garcia-Garcia JJ; Dominguez A; Sa-Leao R; Muñoz-Almagro C; Microbiol Spectr; 2021 Dec; 9(3):e0115021. PubMed ID: 34878302 [TBL] [Abstract][Full Text] [Related]
9. The status of invasive pneumococcal disease among children younger than 5 years of age in north-west Lombardy, Italy. Riva E; Salvini F; Garlaschi ML; Radaelli G; Giovannini M BMC Infect Dis; 2012 May; 12():106. PubMed ID: 22554011 [TBL] [Abstract][Full Text] [Related]
10. Epidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk factors. Backhaus E; Berg S; Andersson R; Ockborn G; Malmström P; Dahl M; Nasic S; Trollfors B BMC Infect Dis; 2016 Aug; 16():367. PubMed ID: 27487784 [TBL] [Abstract][Full Text] [Related]
11. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine. Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249 [TBL] [Abstract][Full Text] [Related]
12. Invasive Pneumococcal Disease Among HIV-Infected and HIV-Uninfected Adults in a Large Integrated Healthcare System. Marcus JL; Baxter R; Leyden WA; Muthulingam D; Yee A; Horberg MA; Klein DB; Towner WJ; Chao CR; Quesenberry CP; Silverberg MJ AIDS Patient Care STDS; 2016 Oct; 30(10):463-470. PubMed ID: 27749111 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use. Pilishvili T; Zell ER; Farley MM; Schaffner W; Lynfield R; Nyquist AC; Vazquez M; Bennett NM; Reingold A; Thomas A; Jackson D; Schuchat A; Whitney CG Pediatrics; 2010 Jul; 126(1):e9-17. PubMed ID: 20547641 [TBL] [Abstract][Full Text] [Related]
14. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)]. Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998 [TBL] [Abstract][Full Text] [Related]
15. The impact of the changing pneumococcal national immunisation program among older Australians. Menzies R; Stein AN; Booy R; Van Buynder PG; Litt J; Cripps AW Vaccine; 2021 Jan; 39(4):720-728. PubMed ID: 33384189 [TBL] [Abstract][Full Text] [Related]
16. Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Pandemic and Nonpandemic Influenza Periods. Hernández S; Muñoz-Almagro C; Ciruela P; Soldevila N; Izquierdo C; Codina MG; Díaz A; Moraga-Llop F; García-García JJ; Domínguez Á J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31189583 [TBL] [Abstract][Full Text] [Related]
18. Prospective surveillance study of invasive pneumococcal disease among urban children in the Philippines. Capeding MR; Bravo L; Santos J; Kilgore PE; Kim SA; Balter I; Hubler R; Ye J; Moscariello M Pediatr Infect Dis J; 2013 Oct; 32(10):e383-9. PubMed ID: 23629024 [TBL] [Abstract][Full Text] [Related]
19. Smoking and alcohol abuse are the most preventable risk factors for invasive pneumonia and other pneumococcal infections. Grau I; Ardanuy C; Calatayud L; Schulze MH; Liñares J; Pallares R Int J Infect Dis; 2014 Aug; 25():59-64. PubMed ID: 24853638 [TBL] [Abstract][Full Text] [Related]
20. Epidemiology of invasive pneumococcal disease in indigenous and non-indigenous adults in northwestern Ontario, Canada, 2006-2015. Dalcin D; Sieswerda L; Dubois S; Ulanova M BMC Infect Dis; 2018 Dec; 18(1):621. PubMed ID: 30514226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]